British Columbia Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.72M | Buy |
15,583
+1,347
| +9% | +$917K | 0.06% | 251 |
|
|
2026
Q1 | $11M | Sell |
14,236
-4,249
| -23% | -$3.25M | 0.06% | 214 |
|
|
2025
Q4 | $14.3M | Buy |
18,485
+3,229
| +21% | +$2.19M | 0.08% | 208 |
|
|
2025
Q3 | $8.58M | Sell |
15,256
-1,573
| -9% | -$889K | 0.05% | 259 |
|
|
2025
Q2 | $8.84M | Sell |
16,829
-3,840
| -19% | -$2.14M | 0.05% | 257 |
|
|
2025
Q1 | $13.1M | Sell |
20,669
-92
| -0.4% | -$63.3K | 0.08% | 208 |
|
|
2024
Q4 | $14.8M | Buy |
20,761
+2,678
| +15% | +$2.25M | 0.09% | 196 |
|
|
2024
Q3 | $19M | Sell |
18,083
-2,591
| -13% | -$2.88M | 0.11% | 146 |
|
|
2024
Q2 | $21.7M | Buy |
20,674
+7,840
| +61% | +$7.6M | 0.13% | 139 |
|
|
2024
Q1 | $12.4M | Buy |
12,834
+546
| +4% | +$519K | 0.09% | 171 |
|
|
2023
Q4 | $10.8M | Buy |
12,288
+2,478
| +25% | +$2.04M | 0.09% | 172 |
|
|
2023
Q3 | $8.07M | Buy |
9,810
+115
| +1% | +$90.4K | 0.08% | 188 |
|
|
2023
Q2 | $6.97M | Buy |
9,695
+140
| +1% | +$108K | 0.06% | 222 |
|
|
2023
Q1 | $7.85M | Buy |
9,555
+47
| +0.5% | +$35.4K | 0.08% | 209 |
|
|
2022
Q4 | $6.86M | Sell |
9,508
-1,180
| -11% | -$871K | 0.08% | 216 |
|
|
2022
Q3 | $7.36M | Sell |
10,688
-1,690
| -14% | -$1.06M | 0.08% | 202 |
|
|
2022
Q2 | $7.32M | Sell |
12,378
-3,943
| -24% | -$2.56M | 0.07% | 239 |
|
|
2022
Q1 | $11.4M | Sell |
16,321
-2,147
| -12% | -$1.36M | 0.07% | 225 |
|
|
2021
Q4 | $11.7M | Sell |
18,468
-897
| -5% | -$552K | 0.07% | 255 |
|
|
2021
Q3 | $11.7M | Sell |
19,365
-124
| -0.6% | -$77K | 0.07% | 246 |
|
|
2021
Q2 | $10.9M | Buy |
19,489
+2,280
| +13% | +$1.16M | 0.07% | 268 |
|
|
2021
Q1 | $8.14M | Sell |
17,209
-483
| -3% | -$235K | 0.06% | 278 |
|
|
2020
Q4 | $8.55M | Buy |
17,692
+198
| +1% | +$107K | 0.06% | 264 |
|
|
2020
Q3 | $9.79M | Buy |
17,494
+1,331
| +8% | +$807K | 0.08% | 218 |
|
|
2020
Q2 | $10.1M | Buy |
16,163
+7,307
| +83% | +$4.15M | 0.1% | 187 |
|
|
2020
Q1 | $4.32M | Sell |
8,856
-10,245
| -54% | -$4.23M | 0.07% | 233 |
|
|
2019
Q4 | $7.17M | Buy |
19,101
+7,977
| +72% | +$2.68M | 0.05% | 277 |
|
|
2019
Q3 | $3.09M | Sell |
11,124
-15,168
| -58% | -$4.49M | 0.03% | 460 |
|
|
2019
Q2 | $8.23M | Sell |
26,292
-8,307
| -24% | -$2.77M | 0.07% | 284 |
|
|
2019
Q1 | $14.2M | Sell |
34,599
-532
| -2% | -$219K | 0.13% | 160 |
|
|
2018
Q4 | $13.1M | Buy |
35,131
+1,940
| +6% | +$710K | 0.12% | 187 |
|
|
2018
Q3 | $13.4M | Sell |
33,191
-9,139
| -22% | -$3.48M | 0.14% | 163 |
|
|
2018
Q2 | $14.6M | Sell |
42,330
-23,295
| -35% | -$7.29M | 0.13% | 176 |
|
|
2018
Q1 | $22.6M | Sell |
65,625
-237
| -0.4% | -$82.4K | 0.17% | 138 |
|
|
2017
Q4 | $24.8M | Buy |
65,862
+9,157
| +16% | +$3.71M | 0.17% | 138 |
|
|
2017
Q3 | $25.4M | Buy |
56,705
+3,496
| +7% | +$1.66M | 0.2% | 127 |
|
|
2017
Q2 | $26.1M | Sell |
53,209
-2,890
| -5% | -$1.26M | 0.21% | 114 |
|
|
2017
Q1 | $21.7M | Buy |
56,099
+13,998
| +33% | +$5.19M | 0.17% | 140 |
|
|
2016
Q4 | $15.5M | Buy |
42,101
+5,020
| +14% | +$1.91M | 0.14% | 173 |
|
|
2016
Q3 | $14.9M | Sell |
37,081
-6,012
| -14% | -$2.41M | 0.15% | 162 |
|
|
2016
Q2 | $15M | Hold |
43,093
| – | – | 0.13% | 177 |
|
|
2016
Q1 | $15.5M | Buy |
43,093
+1,500
| +4% | +$618K | 0.15% | 158 |
|
|
2015
Q4 | $22.6M | Sell |
41,593
-6,974
| -14% | -$3.78M | 0.22% | 109 |
|
|
2015
Q3 | $22.6M | Buy |
48,567
+3,778
| +8% | +$2.03M | 0.23% | 109 |
|
|
2015
Q2 | $22.8M | Buy |
44,789
+4,351
| +11% | +$2.12M | 0.22% | 118 |
|
|
2015
Q1 | $18.3M | Sell |
40,438
-295
| -0.7% | -$125K | 0.16% | 157 |
|
|
2014
Q4 | $16.7M | Buy |
40,733
+6,886
| +20% | +$2.71M | 0.14% | 188 |
|
|
2014
Q3 | $12.2M | Sell |
33,847
-3,356
| -9% | -$1.12M | 0.1% | 243 |
|
|
2014
Q2 | $10.5M | Sell |
37,203
-6,661
| -15% | -$1.97M | 0.09% | 284 |
|
|
2014
Q1 | $13.2M | Sell |
43,864
-12,116
| -22% | -$3.73M | 0.11% | 227 |
|
|
2013
Q4 | $15.4M | Buy |
55,980
+5,372
| +11% | +$1.55M | 0.12% | 209 |
|
|
2013
Q3 | $15.8M | Buy |
50,608
+8,286
| +20% | +$2.18M | 0.13% | 183 |
|
|
2013
Q2 | $9.52M | Buy |
+42,322
| New | +$9.86M | 0.08% | 296 |
|
Other funds holding REGN
British Columbia Investment Management's REGN Position: Q2 2026 in Review
British Columbia Investment Management increased its Regeneron Pharmaceuticals (REGN) stake by 9.5% in Q2 2026, buying an estimated $917K and bringing the position to 15,583 shares worth $9.72M. The position accounts for 0.06% of the portfolio, ranked #251.
British Columbia Investment Management first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $26.1M in Q2 2017. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- British Columbia Investment Management held 15,583 shares of Regeneron Pharmaceuticals worth $9.72M as of Q2 2026.
- British Columbia Investment Management bought 1,347 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $917K.
- Regeneron Pharmaceuticals made up 0.06% of British Columbia Investment Management's portfolio in Q2 2026, its #251 holding.
- British Columbia Investment Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- British Columbia Investment Management's Regeneron Pharmaceuticals position peaked at $26.1M in Q2 2017.
- 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on British Columbia Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.